Loading organizations...
§ Private Profile · Austin, TX, USA
Pharmaceutical company targeting lung injury and fibrosis treatments.
Lung Therapeutics has raised $51.9M across 3 funding rounds.
Lung Therapeutics has raised $51.9M in total across 3 funding rounds.
Lung Therapeutics has raised $51.9M in total across 3 funding rounds.
Lung Therapeutics's investors include Aaron Fletcher, UT Horizon Fund, Steelhead Capital.
Lung Therapeutics has raised $51.9M across 3 funding rounds. Most recently, it raised $36.0M Series C in June 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 4, 2019 | $36M Series C | — | Aaron Fletcher | Announced |
| Jun 7, 2017 | $14.3M Series B | Aaron Fletcher | UT Horizon Fund | Announced |
| Oct 28, 2014 | $1.6M Series A | Aaron Fletcher, Steelhead Capital | — | Announced |